|
ZNF616 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.93710000040426E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44400000021439E-07 |
| Normal-vs-Stage2 |
1.584960E-04 |
| Normal-vs-Stage3 |
7.30429999817872E-08 |
| Normal-vs-Stage4 |
1.44330000173554E-08 |
| Stage1-vs-Stage2 |
2.526400E-01 |
| Stage1-vs-Stage3 |
2.122400E-01 |
| Stage1-vs-Stage4 |
4.032100E-02 |
| Stage2-vs-Stage3 |
6.350100E-02 |
| Stage2-vs-Stage4 |
2.076100E-02 |
| Stage3-vs-Stage4 |
4.737400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.28500000032383E-07 |
| Normal-vs-AfricanAmerican |
9.97470000000389E-05 |
| Normal-vs-Asian |
8.03289999962153E-07 |
| Caucasian-vs-AfricanAmerican |
7.109800E-01 |
| Caucasian-vs-Asian |
8.096400E-01 |
| AfricanAmerican-vs-Asian |
6.146200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.97709999991436E-07 |
| Normal-vs-Female |
1.98690000008384E-07 |
| Male-vs-Female |
9.087800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.36500000033924E-07 |
| Normal-vs-Age(41-60Yrs) |
1.96719999956407E-07 |
| Normal-vs-Age(61-80Yrs) |
6.56059999992742E-07 |
| Normal-vs-Age(81-100Yrs) |
2.281600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.254400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.837200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.941000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.764800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.507400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.986800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.552770E-01 |
| Classical-VS-Follicular |
8.661400E-01 |
| Classical-VS-Other |
6.627200E-01 |
| Classical-VS-Normal |
7.38480000039843E-07 |
| Tall-VS-Follicular |
1.415210E-01 |
| Tall-VS-Other |
7.716200E-01 |
| Tall-VS-Normal |
1.37569999947296E-07 |
| Follicular-VS-Other |
6.762400E-01 |
| Follicular-VS-Normal |
3.78329999994875E-06 |
| Other-VS-Normal |
2.425700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.72049999989244E-07 |
| Normal-vs-N1 |
4.78210004928314E-09 |
| N0-vs-N1 |
1.944470E-02 |
|
|
